A Case for Reframing ‘Skin of Color’
The term that transformed dermatology is now blurring the very distinctions it was meant to sharpen.
By
Kerri Miller
March 20, 2026
Clinical Scorecard: A Case for Reframing ‘Skin of Color’
At a Glance
Category Detail
Condition Skin of Color (SOC) Key Mechanisms Variability in melanin distribution, UV sensitivity, pigmentary genetics, and treatment response. Target Population Patients with darker skin types, particularly Fitzpatrick types V and VI. Care Setting Dermatology clinics and research contexts.
Key Highlights
The Fitzpatrick scale inadequately represents darker skin types. SOC has evolved to encompass equity in education and research. SOC can obscure clinically meaningful differences among patients. A granular approach to SOC is proposed, focusing on specific components. Tools for measuring pigment phenotype are underused in clinical practice. Guideline-Based Recommendations
Diagnosis
Clarify which SOC dimension is relevant in clinical contexts. Management
Utilize tools like ITA, Melanin Index, or Monk Skin Tone for assessing pigment phenotype. Monitoring & Follow-up
Consider pigment-linked clinical risk modifiers in treatment plans. Risks
Be aware of postinflammatory hyperpigmentation and keloid tendency in SOC patients. Patient & Prescribing Data
Individuals with Fitzpatrick types V and VI.
Individualized care is essential, considering specific pigment and sociocultural factors.
Clinical Best Practices
Integrate training on SOC components into dermatology practice. Encourage institutional endorsement for the use of measurement tools. Related Resources & Content
